<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03116789</url>
  </required_header>
  <id_info>
    <org_study_id>NP105004</org_study_id>
    <nct_id>NCT03116789</nct_id>
  </id_info>
  <brief_title>Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis</brief_title>
  <official_title>Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GenMont Biotech Incorporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kuo General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>GenMont Biotech Incorporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the ameliorative effects of oral probiotics on
      bacterial vaginosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To analyze the oral Lactobacillus rhamnosus with Lactobacillus acidophilus or Lactobacillus
      rhamnosus with Lactobacillus plantarum could be ameliorative effects for bacterial vaginosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 11, 2017</start_date>
  <completion_date type="Anticipated">April 10, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, Parallel, open lable Study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nugent Score</measure>
    <time_frame>4 weeks</time_frame>
    <description>The degree of decline for Nugent score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vaginal pH</measure>
    <time_frame>4 weeks</time_frame>
    <description>Vaginal pH value changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal secretions microflora</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in vaginal secretions microflora</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Bacterial Vaginosis</condition>
  <arm_group>
    <arm_group_label>VGA-1(Probiotics)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus rhamnosus and Lactobacillus acidophilus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VGA-2(Probiotics)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus rhamnosus and Lactobacillus plantarum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>probiotics</intervention_name>
    <description>Two capsules for daily</description>
    <arm_group_label>VGA-1(Probiotics)</arm_group_label>
    <arm_group_label>VGA-2(Probiotics)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed Consent Form.

          -  Subjects with bacterial vaginosis and Nugent score as 4-10

          -  Subjects in age of 20-55 years old

          -  Regularly menstruating premenopausal women (normal menstrual function (Eumenorrhoea)
             shall mean regular menstrual bleeding pattern every 28 plus/minus 10 days)

          -  Forbidden sexual behavior was required 72 hours before all visits

        Exclusion Criteria:

          -  Subjects are pregnant, lactating or planning to become pregnant.

          -  Allergy to test products (raw material components included: Anhydrous glucose,
             Magnesium stearate, Fructooligosaccharides, Microcrystalline cellulose, Lactobacillus,
             etc.)

          -  Bleeding from genital tract of unknown aetiology.

          -  Congenital and acquired immunodeficiencies.

          -  Diabetes

          -  Mental illness

          -  Malignant tumor

          -  Application of NuvaRing hormonal contraceptive vaginal ring

          -  Application of mechanical contraceptives, such as: diaphragms, intrauterine
             contraceptive insert, except condom

          -  Application of hormonal preparations, such as: Vagifem, Ovestin and vaginal estrogens
             in reproductive period.

          -  Mycotic vaginitis

          -  Antibiotic(unless indicated by PI) and steroids therapy during this trial.

          -  Use of oral or vaginal probiotic products (sachet, capsule, or tablet) four weeks
             before V1.

          -  Participation in another clinical study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ta-Chin Lin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuo General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ta-Chin Lin</last_name>
    <phone>06-2221111</phone>
    <phone_ext>5830</phone_ext>
    <email>tachin25@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yun-Shiuan Tien</last_name>
    <phone>06-5052151</phone>
    <phone_ext>333</phone_ext>
    <email>tientien@genmont.com.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KUO general hospital</name>
      <address>
        <city>Tainan</city>
        <zip>Minsheng Road, Sec 2, No.22</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <last_update_submitted>October 2, 2017</last_update_submitted>
  <last_update_submitted_qc>October 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginal Diseases</mesh_term>
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

